This report aims to provide insights into the global market. It provides valuable information on anatomic pathology product & service and application. Details on regional Anatomical pathology markets for these segments are also presented in this report. In addition, leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.
The anatomic pathology market is expected to reach USD 21.9 billion by 2021 from USD 16.2 billion in 2016, at a CAGR of 6.1%.
Market report provides a detailed overview of the major drivers, restraints, challenges, opportunities, trends and strategies impacting the anatomic pathology market, along with revenue estimates & forecasts and market share analysis.
Get More Information : https://www.marketsandmarkets.com/Market-Reports/anatomic-pathology-market-137323145.html
The global anatomic pathology market is segmented on the basis of product & service and application. Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The anatomic pathology market is witnessing high growth due to factors such as increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure.
By Type:
The anatomic pathology market is segmented into disease diagnosis, drug discovery & development, and others applications. In 2016, the disease diagnosis segment accounted for the largest share of the market. The growth in this segment primarily attributed to increasing prevalence of chronic diseases.
On the basis of product and service, the anatomic pathology market is segmented into instruments, consumables, and services. In 2016, the services segment accounted for the largest share of the market. This growth can be attributed to the increasing prevalence of chronic diseases and the subsequent growth in the number of anatomic pathology tests.
Prominent Players:
Some of the major players operating in the anatomic pathology market are F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.).
